"Since the early 1990s, drug companies that had built their businesses on early antibiotic research have been leaving the field. As a consequence, there has been a steady decline in the number of new antibiotics approved by the FDA - even as the existing ones are losing ground to a surge of drug-resistant bacterial strains such as Staphylococcus aureus. In the five-year period from 1983 through 1987, the FDA approved 16 new antibiotics. During a similar five-year span that ended last year, only five made the cut."
Sabin Russel
San Francisco Chronicle
January 28. 2008
Read More...